The Dental Health Department is offering this grant to support research aimed at establishing effective interventions and programs to combat opioid drug misuse and abuse. This grant is for the purpose of managing, reducing, and preventing opioid misuse, specifically by aligning the prescribing practices of dental professionals with the latest scientific evidence. Applicants are encouraged to propose innovative strategies that will educate dental practitioners on safe opioid prescribing, identify at-risk patients, and implement alternative pain management techniques. The ultimate goal is to reduce the incidence of opioid addiction and overdose by improving dental prescribing habits and fostering a greater understanding of the risks associated with opioid use in the dental setting.
Opportunity ID: 338468
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DE-23-010 |
Funding Opportunity Title: | The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 02, 2022 |
Last Updated Date: | Mar 02, 2022 |
Original Closing Date for Applications: | May 10, 2022 |
Current Closing Date for Applications: | May 10, 2022 |
Archive Date: | Jun 15, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $400,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | City or township governments Small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Independent school districts State governments County governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) is soliciting applications to support the planning and implementation of research to establish effective interventions or programs to manage, reduce, or prevent opioid drug misuse and align the opioid prescribing practices of dental professionals with scientific evidence. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-23-010.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 338468 Full Announcement-RFA-DE-23-010 -> RFA-DE-23-010-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00272356 | Apr 09, 2022 | May 10, 2022 | View |
Package 1
Mandatory forms
338468 RR_SF424_5_0-5.0.pdf
338468 PHS398_CoverPageSupplement_5_0-5.0.pdf
338468 RR_OtherProjectInfo_1_4-1.4.pdf
338468 PerformanceSite_4_0-4.0.pdf
338468 RR_KeyPersonExpanded_4_0-4.0.pdf
338468 RR_Budget10_3_0-3.0.pdf
338468 PHS398_ResearchPlan_4_0-4.0.pdf
338468 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338468 RR_SubawardBudget10_30_3_0-3.0.pdf
338468 PHS_AssignmentRequestForm_3_0-3.0.pdf